← Open Payments lookup

ERIN COLE: Open Payments

NPI 1255033411 · NEW ORLEANS, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$639 in 29 payments from 12 companies in 2025. Trend: 2023 $162 · 2024 $812 · 2025 $639

Food & beverage: $639
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)6$149
Janssen Pharmaceuticals, Inc3$85
Axsome Therapeutics, Inc.3$66
E.R. Squibb & Sons, L.L.C.3$54
ABBVIE INC.3$53
Braeburn Inc.3$47
Alkermes, Inc.2$47
Teva Pharmaceuticals USA, Inc.2$37
Neurocrine BioSciences, Inc.1$32
Otsuka America Pharmaceutical, Inc.1$29

Products named: CAPLYTA, INVEGA, Auvelity, COBENFY, VRAYLAR, BRIXADI, INGREZZA, REXULTI.

Industry payments across LA — which companies pay providers there.